Company intelligence / Profile preview

HealthBeacon

Ownership: Private
Employees: ~70
Development stage: Other

Overview

Peer-reviewed studies show up to a 26% increase in medication adherence and a 19% improvement in persistence at month twelve among users of the HealthBeacon system. Adoption rates exceed many consumer self-tracking technologies with approximately 77–80% adoption and high persistence among adopters. The system has tracked over half a million injections globally. The ICMS provides actionable data to patients and clinicians to improve outcomes.

Therapeutic areas: Immunology
Modalities: Device (smart sharps bin for injectable medications)Digital health platform (adherence monitoring)Non-pharmacological therapy (adherence support tools)
Industry: Digital Health Medical Devices

Partnerships

AbbVie – supported European rollout of Humira with exclusive contract from ~2017–2019Teva – partnership in Ireland for patient servicesNovartis – collaboration on sustainable medical waste solutions

Beyond the preview

Go deeper on HealthBeacon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HealthBeacon.

Explore the full profile